Empaford-Met 12.5mg/1000mg Tablet 10.0 tablets in 1 strip

Last Updated: March 25th, 2026

Empaford-Met 12.5mg/1000mg Tablet is a product of Astra Care Pharmaceuticals Pvt. Ltd

Composition: Empagliflozin (12.5mg) + Metformin (1000mg)

Pack of 10 tablet

₹ 176.25

Check for the Availability! Please do contact!

Limited Stock

All Details About Empaford-Met 12.5mg/1000mg Tablet

Find out detailed description, uses, directions of use, side effects, warnings and precautions, frequently asked questions about Empaford-Met 12.5mg/1000mg Tablet

Description:

Empaford-Met 12.5mg/1000mg Tablet is a combination medicine that helps control blood sugar levels. This medicine is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It helps in proper utilisation of insulin, thereby lowering the blood sugar level.

Empaford-Met 12.5mg/1000mg Tablet should be taken with food at any time of day but you should try to take it at the same time every day. The dose will be decided by your doctor. Don’t stop taking it without asking your doctor. If you do, your blood sugar levels may increase and put you at risk of serious complications like kidney damage and blindness. This medicine is only part of a treatment program that should include a healthy diet, regular exercise, and weight reduction as advised by your doctor.

The most common side effects of this medicine include taste changes, nausea, vomiting, diarrhea, joint pain, urinary tract infection, and yeast infections. Drinking plenty of fluids while using it will help prevent dehydration. Some people may develop fungal infections in the genital area. Keeping good hygiene can help prevent this.

Earlier taking this medicine, inform your doctor if you have any kidney or liver problems or a urinary tract infection or if you are on water pills (diuretics). Pregnant or breastfeeding women should also consult their doctor before taking it. Avoid excessive alcohol intake while taking it as this may increase the risk of developing some side effects. Monitor your blood sugar levels regularly while taking this medicine.

Uses:

Treatment of Type 2 diabetes mellitus

Directions For Use:

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Empaford-Met 12.5mg/1000mg Tablet may be taken with or without food.

Side Effects:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Ordinary side effects of Empaford-Met

Urinary tract infection
Genital fungal infection
Nausea
Vomiting
Nasopharyngitis (inflammation of the throat and nasal passages)
Flatulence
Hypoglycemia (low blood glucose level)
Joint pain

Warning & Precautions:

Alcohol

CAUTION

Alcohol should be used with caution while taking Empaford-Met 12.5mg/1000mg Tablet.

Pregnancy

CONSULT YOUR DOCTOR

The safety of Empaford-Met 12.5mg/1000mg Tablet during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient. Your doctor will weigh the benefits and any potential risks before prescribing.

Breast feeding

CONSULT YOUR DOCTOR

Empaford-Met 12.5mg/1000mg Tablet may be unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. It should be used only if the expected benefit outweighs the potential risk. Please consult your doctor.

Driving

UNSAFE

Empaford-Met 12.5mg/1000mg Tablet may decrease alertness, affect your vision, or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney

UNSAFE

Empaford-Met 12.5mg/1000mg Tablet is unsafe to use in patients with kidney disease and should be avoided.

Liver

CAUTION

Empaford-Met 12.5mg/1000mg Tablet should be used with caution in patients with liver disease. Dose adjustment may be needed.

FAQs:

What is Empaford-Met 12.5mg/1000mg Tablet used for?

Empaford-Met 12.5mg/1000mg Tablet is a combination medicine used to treat type 2 diabetes. Along with a proper diet and regular exercise, it helps improve blood sugar control in adults. It works by enhancing the body’s ability to use insulin effectively, thereby lowering blood sugar levels.

Who should not take Empaford-Met 12.5mg/1000mg Tablet?

People should not take Empaford-Met 12.5mg/1000mg Tablet if they have severe kidney failure (eGFR below 30 mL/min/1.73 m²), during diabetic pre-coma, with active ketoacidosis or lactic acidosis, in severe liver disease, in acute conditions that reduce oxygen to tissues (such as decompensated heart failure or shock), or with a known allergy to either ingredient present in it.

What serious side effects of Empaford-Met 12.5mg/1000mg Tablet need urgent care?

Perceivek emergency help if you experience serious side effects of Empaford-Met 12.5mg/1000mg Tablet, such as signs of lactic acidosis (trouble breathing, stomach pain, severe weakness, confusion, vomiting), or diabetic ketoacidosis (nausea, vomiting, belly pain, deep breathing, unusual fatigue, fruity breath).

Can Empaford-Met 12.5mg/1000mg Tablet affect the kidneys or fluid balance?

Affirmative, empagliflozin medicine present in Empaford-Met 12.5mg/1000mg Tablet increases urination and can lead to dehydration and low blood pressure, especially in older adults or with diuretics. Kidney function should be checked before starting and periodically during treatment, and more often if kidney function is at risk.

Are there infection risks to watch for during Empaford-Met 12.5mg/1000mg Tablet?

Affirmative, urinary tract infections (including kidney infection and sepsis) and genital infections can occur during Empaford-Met 12.5mg/1000mg Tablet treatment. Highly rare cases of a serious genital area infection called Fournier’s gangrene need urgent surgery and antibiotics. Perceivek care for pain, swelling, redness in the genital/perineal area with fever or feeling unwell.

Can Empaford-Met 12.5mg/1000mg Tablet cause low blood sugar?

Empaford-Met 12.5mg/1000mg Tablet alone has a low risk of hypoglycaemia, but the risk increases when used with insulin or sulfonylureas. A dose reduction of insulin or sulfonylurea may be needed to lower the risk of low blood sugar.

Written by:
Dr. Lokanish
M.B.B.S.

Reviewed by:
Dr. Sureshbabu Yadav
M.B.B.S., DIP.DIAB, F.R.S.H

Disclaimer:

Getomeds primary intention is to ensure that its consumers get information that is reviewed by experts, accurate, and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all of your concerns about any disease or medication. Do not disregard or postpone seeking professional medical advice because of something you read on Getomeds. Our mission is to support, not replace, the doctor-patient relationship.